NFKB1 and rheumatoid arthritis: In PBMCs from RA patients, the disease-related high concentration of pro-inflammatory cytokines induces expression of NF-κB and CREB as well as activation of the PI3K/Akt pathway, leading to A2R and A3R upregulation [54,55,56].